LDHB is upregulated in cancer associated adipocytes in the breast cancer microenvironment, suggesting that cancer cells, including myeloma cells, could modulate lactate metabolism in the microenvironment (56)—a process that might be critical in patient responses to carfilzomib (57). This evidence concerns the gene LDHB and plasma cell myeloma.